The global eClinical solutions market was valued at USD 10.28 billion in 2024 and is projected to reach USD 22.74 billion by 2030, registering a robust CAGR of 14.39% from 2025 to 2030. Market expansion is primarily driven by the rising volume of research and development activities undertaken by pharmaceutical and biopharmaceutical companies, coupled with the increasing complexity of clinical trials that necessitate advanced digital solutions.

Key Market Trends and Insights

North America dominated the global eClinical solutions market in 2024, accounting for 48.88% of total revenue, supported by a mature clinical research ecosystem and strong regulatory oversight. The U.S. emerged as the largest country-level market, reflecting high adoption of digital platforms across clinical trial workflows.

From a product perspective, the Clinical Trial Management System (CTMS) segment held the leading position, capturing 20.27% of market revenue in 2024, owing to its widespread use in trial planning, tracking, and reporting. Based on delivery mode, web- and cloud-based solutions dominated the market due to their scalability, real-time accessibility, and cost efficiency.

By end use, Contract Research Organizations (CROs) accounted for the largest revenue share in 2024, driven by the increasing outsourcing of clinical trials by pharmaceutical and biotechnology companies. In terms of development phase, Phase III trials dominated the market, reflecting the high volume and complexity of late-stage clinical studies requiring comprehensive data management and monitoring tools.

Market Size & Forecast

• 2024 Market Size: USD 10.28 Billion
• 2030 Projected Market Size: USD 22.74 Billion
• CAGR (2025–2030): 14.39%
• Largest Regional Market (2024): North America

The growing integration of software platforms across clinical trial operations is expected to further accelerate market growth. Additionally, the increasing trend toward outsourcing and externalization of clinical trials by major pharmaceutical and biotechnology firms is anticipated to significantly boost demand for eClinical solutions throughout the forecast period.

A stringent regulatory framework for clinical trials, particularly in developed economies such as the U.S., is also contributing to market expansion. Regulatory bodies including the U.S. Department of Health and Human Services and the National Institutes of Health are reinforcing clinical trial registration requirements and encouraging data transparency. This has intensified the need for robust digital platforms capable of ensuring compliance, safety monitoring, and data integrity. Furthermore, rising government funding to support clinical research and the expanding end-user base are expected to positively influence market growth.

Order a free sample PDF of the eClinical Solutions Market Intelligence Study, published by Grand View Research.

Key eClinical Solutions Companies Insights

Leading players in the eClinical solutions market are actively pursuing strategic initiatives such as partnerships, mergers, acquisitions, and geographic expansion to strengthen their market position and broaden their solution portfolios.

Major Companies Operating in the Market:

• Datatrak International, Inc.
• Oracle
• Parexel International Corporation
• Dassault Systèmes
• Bioclinica
• CRF Health
• ERT Clinical
• eClinicalWorks
• Merative (formerly IBM Watson Health; acquired by Francisco Partners in June 2022)
• Anju Life Sciences Software
• eClinical Solutions
• Maxisit
• IQVIA
• Castor
• Veeva Systems
• RealTime Software Solutions, LLC
• Medidata Solution, Inc.
• ICON, plc

Prominent Providers of AI-Powered eClinical Solutions:

• Deep 6 AI (acquired by Tempus on March 12, 2025)
• Phesi
• Curebase
• Saama
• Suvoda LLC (merged with Greenphire in April 2025)
• Cencora Pharmalex (acquired by AmerisourceBergen Corporation in January 2023)
• Clinion
• Jeeva Clinical Trials Inc.
• Trial Interactive by TransPerfect

Conclusion

In conclusion, the global eClinical solutions market is poised for significant growth through 2030, driven by rising clinical trial complexity, increasing R&D investments, regulatory compliance requirements, and the accelerating shift toward digital and cloud-based platforms. Strong adoption across CROs, late-stage clinical trials, and emerging markets, combined with ongoing innovation in AI-powered solutions, is expected to sustain robust market expansion over the forecast period.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.